A detailed history of Kestra Advisory Services, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 8,837 shares of MRNA stock, worth $325,643. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,837
Previous 11,306 21.84%
Holding current value
$325,643
Previous $1.34 Million 56.04%
% of portfolio
0.0%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$63.64 - $125.14 $157,127 - $308,970
-2,469 Reduced 21.84%
8,837 $590,000
Q2 2024

Aug 14, 2024

SELL
$101.21 - $166.61 $94,530 - $155,613
-934 Reduced 7.63%
11,306 $1.34 Million
Q1 2024

May 15, 2024

SELL
$85.37 - $115.44 $154,007 - $208,253
-1,804 Reduced 12.85%
12,240 $1.3 Million
Q4 2023

Feb 14, 2024

SELL
$69.51 - $104.43 $506,310 - $760,668
-7,284 Reduced 34.15%
14,044 $1.4 Million
Q3 2023

Nov 09, 2023

BUY
$96.41 - $126.61 $838,381 - $1.1 Million
8,696 Added 68.84%
21,328 $2.2 Million
Q2 2023

Aug 11, 2023

SELL
$118.5 - $160.53 $221,832 - $300,512
-1,872 Reduced 12.91%
12,632 $1.53 Million
Q1 2023

May 12, 2023

SELL
$135.66 - $197.02 $262,230 - $380,839
-1,933 Reduced 11.76%
14,504 $2.23 Million
Q4 2022

Jan 31, 2023

SELL
$118.38 - $210.04 $24,031 - $42,638
-203 Reduced 1.22%
16,437 $2.95 Million
Q3 2022

Nov 01, 2022

SELL
$118.07 - $194.18 $42,741 - $70,293
-362 Reduced 2.13%
16,640 $1.97 Billion
Q2 2022

Aug 12, 2022

SELL
$117.13 - $176.59 $364,508 - $549,548
-3,112 Reduced 15.47%
17,002 $2.43 Million
Q1 2022

Apr 26, 2022

BUY
$126.46 - $235.05 $321,334 - $597,262
2,541 Added 14.46%
20,114 $3.46 Million
Q4 2021

Jan 20, 2022

SELL
$225.82 - $368.51 $2.23 Million - $3.64 Million
-9,888 Reduced 36.01%
17,573 $4.46 Million
Q3 2021

Oct 19, 2021

BUY
$221.9 - $484.47 $1.23 Million - $2.68 Million
5,531 Added 25.22%
27,461 $10.6 Million
Q2 2021

Jul 28, 2021

SELL
$129.91 - $234.98 $617,592 - $1.12 Million
-4,754 Reduced 17.82%
21,930 $5.15 Million
Q1 2021

May 10, 2021

SELL
$109.18 - $185.98 $399,052 - $679,756
-3,655 Reduced 12.05%
26,684 $3.49 Million
Q4 2020

Jan 20, 2021

BUY
$65.74 - $169.86 $855,737 - $2.21 Million
13,017 Added 75.15%
30,339 $3.37 Billion
Q3 2020

Nov 12, 2020

BUY
$54.34 - $94.85 $941,277 - $1.64 Million
17,322 New
17,322 $1.23 Billion

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.